Outcomes of very preterm infants with neonatal hyperglycaemia: a systematic review and meta-analysis

Chandra Prakash Rath1,2, Madhusudhan Shivamallappa1,2, Saravanan Muthusamy1,2

  • 1Neonatology, King Edward Memorial Hospital for Women, Subiaco, Western Australia, Australia.

Insights

Hyperglycaemia in very preterm infants is linked to increased mortality and severe complications like intraventricular hemorrhage and retinopathy of prematurity. Longer duration of high blood sugar worsens these adverse outcomes.

Area of Science:

  • Neonatal Medicine
  • Endocrinology
  • Perinatal Epidemiology

Background:

  • Hyperglycaemia is a common metabolic disturbance in very preterm infants.
  • The association between hyperglycaemia and adverse outcomes in this vulnerable population requires further clarification.

Purpose of the Study:

  • To systematically review and meta-analyze the association between hyperglycaemia and adverse outcomes in very preterm infants (<32 weeks or <1500 g).

Main Methods:

  • Systematic review and meta-analysis of 46 studies including 34,527 infants.
  • Data pooled using random-effects models for adjusted and unadjusted odds ratios (ORs).
  • Subgroup analysis conducted based on study design (cohort and case-control).

Main Results:

  • Unadjusted analysis indicated significant associations between hyperglycaemia and mortality, intraventricular haemorrhage (IVH), retinopathy of prematurity (ROP), sepsis, chronic lung disease, and disability.
  • Adjusted analysis revealed significant associations only for mortality (aOR 2.37), any-grade IVH (aOR 2.60), and any-stage ROP (aOR 3.70).
  • Higher glucose levels (>10 mmol/L) and longer duration of hyperglycaemia were associated with increased odds of mortality and adverse outcomes, respectively. GRADE of evidence was 'Low' or 'Very low'.

Conclusions:

  • Hyperglycaemia in very preterm infants is associated with increased odds of mortality, any-grade IVH, and any-stage ROP.
  • The lack of adjusted ORs in many studies limits definitive conclusions.
  • Further research with robust adjusted analyses is warranted.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.2K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
480
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.0K
Outcomes of Glycolysis01:13

Outcomes of Glycolysis

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
104.8K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.3K